Publishing Knowledge. Connecting Professionals. Advancing Pathology.

45+

Protocols

6

Categories

Step-by-Step

Guides

QC

Tips Included

Routine Stains

The foundational staining techniques used in every histopathology laboratory for general tissue examination and morphological assessment.

Gold Standard

Haematoxylin & Eosin (H&E)

Principle: Haematoxylin, a basic dye, binds to acidic (basophilic) structures such as DNA and RNA in cell nuclei, staining them blue-purple. Eosin, an acidic dye, binds to basic (eosinophilic) structures such as cytoplasmic proteins, collagen and muscle fibres, staining them pink-red.

Reagents Required

  • Harris's or Mayer's haematoxylin
  • Eosin Y (aqueous or alcoholic, 0.5–1%)
  • Acid alcohol (1% HCl in 70% ethanol)
  • Scott's tap water substitute or ammonia water (bluing agent)
  • Graded alcohols (70%, 95%, 100%)
  • Xylene or xylene substitute
  • DPX or suitable mounting medium

Step-by-Step Procedure

  1. Deparaffinise sections in xylene (2 changes, 3–5 minutes each)
  2. Rehydrate through graded alcohols to distilled water (100%, 95%, 70%, 2 minutes each)
  3. Stain in haematoxylin solution (5–15 minutes depending on formulation)
  4. Rinse in running tap water (5 minutes)
  5. Differentiate in acid alcohol (1–2 quick dips)
  6. Rinse in running tap water (1–2 minutes)
  7. Blue in Scott's tap water substitute or ammonia water (1–2 minutes)
  8. Rinse in running tap water (5 minutes)
  9. Counterstain in eosin (1–5 minutes)
  10. Dehydrate through graded alcohols, clear in xylene, mount with DPX

Expected Results

Nuclei: Blue to purple  |  Cytoplasm: Pink to red  |  Collagen: Pale pink  |  Red blood cells: Bright red/orange  |  Muscle fibres: Deep pink

Quality Control Tips

  • Use a known positive control tissue (e.g. appendix) with each batch
  • Check haematoxylin pH regularly (optimal pH 2.5–3.0 for Harris's)
  • Filter haematoxylin before use to remove oxidation precipitate
  • Monitor differentiation carefully — over-differentiation removes nuclear staining
  • Replace eosin when colour intensity diminishes

Common Artefacts

  • Formalin pigment: Brown-black granular deposits; prevented by using neutral buffered formalin
  • Chatterer (chatter) artefact: Parallel lines from dull microtome blade
  • Tissue folds: Overlapping tissue producing darker-staining creases
  • Air bubbles: Under coverslip from inadequate mounting medium
  • Nuclear bubbling: Caused by excessive heat during drying
Carbohydrate Detection

Periodic Acid–Schiff (PAS)

Principle: Periodic acid oxidises vicinal glycol groups (1,2-diols) in carbohydrates to form dialdehydes. These aldehydes react with Schiff's reagent (leucofuchsin) to produce a magenta-coloured compound.

Target Substances

  • Glycogen
  • Neutral mucins (mucopolysaccharides)
  • Basement membranes
  • Fungal cell walls
  • Brush borders of renal tubules

Procedure

  1. Deparaffinise and hydrate sections to distilled water
  2. Oxidise in 0.5–1% periodic acid (5–10 minutes)
  3. Rinse in distilled water
  4. Treat with Schiff's reagent (15–30 minutes)
  5. Wash in running tap water (5–10 minutes) until sections turn pink
  6. Counterstain with haematoxylin (1–2 minutes)
  7. Dehydrate, clear, mount

Expected Results

PAS-positive structures: Magenta/deep pink  |  Nuclei: Blue (haematoxylin counterstain)  |  Background: Pale pink to colourless

Diastase control (PAS-D): Pre-treatment with diastase (amylase) removes glycogen. Structures that are PAS-positive but diastase-resistant include basement membranes, mucins and fungi.

Haematology & Microbiology

Giemsa Stain

Principle: A Romanowsky-type stain composed of methylene blue, eosin and azure dyes. The differential binding of acidic and basic dye components produces polychromatic staining of blood and tissue elements.

Applications

  • Blood smear examination and differential counts
  • Bone marrow aspirate assessment
  • Detection of Helicobacter pylori in gastric biopsies
  • Identification of intracellular parasites (malaria, Leishmania)
  • Mast cell identification

Expected Results

Nuclei/chromatin: Dark blue-purple  |  Cytoplasm (basophilic): Blue  |  Cytoplasm (eosinophilic): Pink-red  |  Bacteria (H. pylori): Dark blue  |  Mast cell granules: Purple-red

Haematology

Wright's Stain

Principle: A polychromatic Romanowsky stain containing methylene blue and eosin in methanol. Widely used for peripheral blood smear examination and differential white blood cell counts.

Applications

  • Differential white blood cell counting
  • Red cell morphology assessment
  • Platelet estimation and morphology
  • Detection of blood parasites

Expected Results

Neutrophil granules: Lilac/pink  |  Eosinophil granules: Bright red-orange  |  Basophil granules: Dark blue-black  |  Lymphocyte cytoplasm: Sky blue  |  Red blood cells: Pink-orange

Special Stains

Histochemical techniques that selectively demonstrate specific tissue components, organisms or deposits not readily identifiable on routine H&E staining.

Connective Tissue

Masson's Trichrome

Target: Collagen fibres

Principle: Differential staining of muscle, collagen and nuclei using three dyes — Weigert's iron haematoxylin, Biebrich scarlet-acid fuchsin, and aniline blue (or light green).

Results: Collagen — blue/green | Muscle & cytoplasm — red | Nuclei — black

Use: Liver fibrosis staging, cardiac fibrosis, renal fibrosis assessment.

Connective Tissue

Reticulin (Gordon & Sweets)

Target: Reticular fibres (type III collagen)

Principle: Silver impregnation technique. Reticular fibres reduce ammoniacal silver to metallic silver, which is then toned with gold chloride.

Results: Reticular fibres — black | Background — grey to pink

Use: Liver architecture assessment, lymph node framework, bone marrow fibrosis grading.

Deposits

Congo Red

Target: Amyloid deposits

Principle: Congo red dye binds to the beta-pleated sheet structure of amyloid fibrils in a highly ordered manner.

Results: Amyloid — salmon pink/red (brightfield); apple-green birefringence under polarised light | Nuclei — blue (haematoxylin counterstain)

Use: Diagnosis of systemic and localised amyloidosis.

Microorganisms

Ziehl–Neelsen (ZN)

Target: Acid-fast bacilli (Mycobacterium tuberculosis, atypical mycobacteria)

Principle: Carbol fuchsin penetrates the waxy mycolic acid cell wall when heated. Acid-alcohol decolourises non-acid-fast organisms, but mycobacteria retain the dye.

Results: Acid-fast bacilli — bright red | Background — blue (methylene blue counterstain)

Use: Tuberculosis diagnosis, leprosy (modified ZN).

Microorganisms

GMS / Grocott's Methenamine Silver

Target: Fungal cell walls (Pneumocystis, Aspergillus, Candida, Histoplasma)

Principle: Chromic acid oxidises polysaccharides in fungal cell walls to aldehydes. These reduce methenamine silver to metallic silver, which deposits on fungal structures.

Results: Fungi — black/dark brown | Background — pale green (light green counterstain)

Use: Detection of fungal infections in tissue sections.

Deposits

Perl's Prussian Blue (Iron Stain)

Target: Haemosiderin (ferric iron, Fe³⁺)

Principle: Ferric iron reacts with potassium ferrocyanide in the presence of hydrochloric acid to form ferric ferrocyanide (Prussian blue), an insoluble blue pigment.

Results: Iron deposits — bright blue | Nuclei — red (neutral red counterstain)

Use: Iron overload assessment, haemochromatosis, sideroblastic anaemia, transfusion haemosiderosis.

Mucins

Alcian Blue

Target: Acid mucopolysaccharides (acid mucins, glycosaminoglycans)

Principle: Alcian blue, a cationic (basic) dye, binds to negatively charged carboxyl and sulphate groups of acid mucins at pH 2.5. At pH 1.0, only strongly acidic sulphated mucins stain.

Results: Acid mucins — blue/turquoise | Nuclei — red (neutral red counterstain)

Use: Identification of acid mucins, Barrett's oesophagus (AB/PAS combination), mesothelioma.

Mucins

Mucicarmine

Target: Epithelial mucin

Principle: Carmine dye in an aluminium-containing solution selectively binds to the acidic groups of epithelial mucin.

Results: Epithelial mucin — deep red/magenta | Capsule of Cryptococcus neoformans — red/magenta | Nuclei — blue/black

Use: Mucin-secreting adenocarcinomas, cryptococcal infection identification.

Lipids

Oil Red O

Target: Neutral lipids, triglycerides, fatty acids

Principle: Oil Red O is a lysochrome (fat-soluble dye) that partitions into lipid droplets, being more soluble in lipid than in the solvent carrier. Requires frozen sections as lipids are dissolved by processing solvents.

Results: Lipids — bright red/orange-red | Nuclei — blue (haematoxylin counterstain)

Use: Fatty liver assessment, lipid storage diseases, fat embolism. Frozen sections only.

Connective Tissue

Elastic Van Gieson (EVG)

Target: Elastic fibres and collagen

Principle: Verhoeff's elastic stain (iron haematoxylin) demonstrates elastic fibres. Van Gieson's counterstain (picric acid + acid fuchsin) differentiates collagen from muscle and other tissues.

Results: Elastic fibres — blue-black/black | Collagen — red | Muscle & cytoplasm — yellow

Use: Vascular pathology, temporal arteritis, emphysema, skin elastic tissue assessment.

Pigments

Fontana–Masson

Target: Melanin, argentaffin granules

Principle: Argentaffin reaction — melanin granules and enterochromaffin cells reduce ammoniacal silver without an external reducing agent, depositing metallic silver on the target.

Results: Melanin — black/dark brown | Argentaffin granules — black | Nuclei — red (nuclear fast red counterstain)

Use: Confirming melanin in pigmented lesions, carcinoid tumour identification.

Deposits

Von Kossa

Target: Calcium deposits (calcium phosphate, calcium carbonate)

Principle: Silver nitrate reacts with the phosphate or carbonate anions associated with calcium deposits. Exposure to strong light reduces the silver salt to metallic silver.

Results: Calcium deposits — black/dark brown | Nuclei — red (nuclear fast red counterstain)

Use: Pathological calcification, calcinosis cutis, calcium oxalate identification (with polarised light).

Immunohistochemistry (IHC)

Immunohistochemistry uses antibodies to detect specific antigens in tissue sections, providing critical information for tumour classification, prognostic assessment and treatment selection.

Pre-treatment

Antigen Retrieval Methods

Formalin fixation causes protein cross-linking that can mask antigenic epitopes. Antigen retrieval reverses this cross-linking to restore antibody binding.

Heat-Induced Epitope Retrieval (HIER)

  • Citrate buffer (pH 6.0): Most commonly used; suitable for nuclear and cytoplasmic antigens
  • EDTA/Tris-EDTA buffer (pH 9.0): Higher pH retrieval; often superior for membrane antigens and some nuclear markers
  • Methods: Pressure cooker, microwave, water bath (95–99°C, 20–40 minutes)

Enzymatic (Proteolytic) Retrieval

  • Proteinase K: Broad-spectrum protease; used for certain surface antigens
  • Pepsin: Acidic protease (pH 2.0); useful for basement membrane components
  • Trypsin: Used for immunoglobulin light chains and some cytokeratins
  • Caution: Over-digestion destroys tissue morphology and antigenicity
Visualisation

Detection Systems

Polymer-Based Detection (Current Standard)

  • Dextran polymer backbone conjugated with multiple secondary antibodies and enzyme molecules (HRP or AP)
  • Higher sensitivity than older methods with reduced background
  • No endogenous biotin interference
  • Examples: EnVision (Dako/Agilent), Novolink (Leica), UltraView (Ventana/Roche)

Avidin-Biotin Complex (ABC) — Legacy Method

  • Biotinylated secondary antibody bridges primary antibody to avidin-biotin-enzyme complex
  • High sensitivity but susceptible to endogenous biotin interference (liver, kidney, brain tissue)
  • Largely replaced by polymer-based systems in modern laboratories
Diagnostic Panels

Common IHC Panels by Organ

Breast Panel

  • ER (Oestrogen Receptor): Nuclear; positive in ~75% of breast carcinomas; Allred scoring (0–8)
  • PR (Progesterone Receptor): Nuclear; positive in ~65% of breast carcinomas; correlates with ER status
  • HER2 (c-erbB-2): Membranous; scored 0, 1+, 2+, 3+; 2+ requires FISH confirmation; guides targeted therapy
  • Ki-67: Nuclear proliferation marker; percentage scoring; prognostic and predictive value

Lung Panel

  • TTF-1 (Thyroid Transcription Factor-1): Nuclear; positive in pulmonary adenocarcinoma (~75%) and thyroid carcinoma
  • Napsin A: Cytoplasmic granular; positive in pulmonary adenocarcinoma; more specific than TTF-1
  • p40: Nuclear; marker for squamous cell carcinoma; highly specific
  • CK5/6: Cytoplasmic; positive in squamous cell carcinoma; used with p40 for squamous differentiation

Lymphoma Panel

  • CD3: T-cell marker (membranous/cytoplasmic)
  • CD20: B-cell marker (membranous); target for rituximab therapy
  • CD30: Membranous/Golgi; positive in Hodgkin lymphoma (Reed-Sternberg cells), ALCL
  • Ki-67: Proliferation index; critical for grading (e.g. follicular lymphoma grading)
  • BCL-2: Anti-apoptotic protein; positive in follicular lymphoma (diagnostic), CLL/SLL
  • BCL-6: Germinal centre marker; positive in follicular lymphoma, DLBCL (GCB subtype)

Melanoma Panel

  • S100: Nuclear and cytoplasmic; highly sensitive but not specific for melanoma (also positive in nerve sheath tumours, cartilage)
  • SOX10: Nuclear; sensitive and specific for melanocytic differentiation; also positive in nerve sheath tumours
  • Melan-A (MART-1): Cytoplasmic; specific for melanocytes; positive in adrenal cortex
  • HMB-45: Cytoplasmic; recognises gp100/Pmel17; typically positive in melanoma, negative in most naevi (useful for invasion assessment)

Gastrointestinal (GI) Panel

  • CDX2: Nuclear; intestinal differentiation marker; positive in colorectal carcinoma (~95%)
  • CK20: Cytoplasmic; positive in colorectal, urothelial, Merkel cell carcinoma
  • CK7: Cytoplasmic; positive in many non-colorectal carcinomas; CK7−/CK20+ pattern favours colorectal origin
  • SATB2: Nuclear; highly specific for colorectal origin; superior to CDX2 alone

Prostate Panel

  • PSA (Prostate-Specific Antigen): Cytoplasmic; specific for prostatic epithelium; may be lost in high-grade carcinomas
  • NKX3.1: Nuclear; highly sensitive and specific for prostatic origin; retained in high-grade tumours
  • P504S/AMACR (Alpha-Methylacyl-CoA Racemase): Cytoplasmic granular; positive in prostatic adenocarcinoma and PIN; useful for small atypical foci
  • p63: Nuclear; basal cell marker; absent in invasive carcinoma; used to confirm loss of basal cells in malignancy
Problem Solving

IHC Troubleshooting

Background Staining

  • Inadequate blocking of endogenous peroxidase or biotin
  • Antibody concentration too high — titrate to optimal dilution
  • Insufficient washing between steps
  • Non-specific protein binding — use appropriate protein block
  • Chromogen incubation too long

Weak or Absent Staining

  • Inadequate antigen retrieval — optimise buffer pH and duration
  • Over-fixation (prolonged formalin >72 hours) — extend retrieval time
  • Under-fixation — poor tissue preservation and inconsistent staining
  • Antibody expired, improperly stored or incorrect dilution
  • Detection system reagent failure — check with known positive control
  • Tissue dried out during procedure

No Staining

  • Omission of a reagent step (primary antibody, secondary, chromogen)
  • Incorrect antibody species — verify primary/secondary compatibility
  • Antigen not expressed in tissue (true negative vs technical failure)
  • Tissue necrotic or severely autolysed
  • Always run positive and negative controls to distinguish technical failure from true negative results

Molecular Techniques

Molecular pathology techniques complement morphology and immunohistochemistry, providing genetic and genomic data essential for precision medicine and targeted therapy selection.

Cytogenetics

FISH (Fluorescence In Situ Hybridization)

Principle: Fluorescently labelled DNA probes hybridise to complementary sequences on chromosomes in tissue sections or cell preparations. Signals are visualised using fluorescence microscopy.

Key applications:

  • HER2 amplification: Breast carcinoma (IHC 2+ reflex testing)
  • ALK rearrangement: Non-small cell lung carcinoma — guides crizotinib therapy
  • BCR-ABL fusion: Chronic myeloid leukaemia — t(9;22) Philadelphia chromosome
  • MYC, BCL2, BCL6 rearrangements: High-grade B-cell lymphoma classification
Molecular Biology

PCR / RT-PCR

Principle: Polymerase chain reaction amplifies specific DNA sequences exponentially through repeated cycles of denaturation, annealing and extension. RT-PCR first reverse-transcribes RNA to cDNA.

Key applications:

  • Clonality assessment in lymphoproliferative disorders (IgH, TCR gene rearrangements)
  • Infectious agent detection (HPV, EBV, CMV, TB)
  • Mutation detection (BRAF V600E, KRAS, EGFR)
  • Microsatellite instability (MSI) testing
  • Minimal residual disease monitoring
Genomics

Next-Generation Sequencing (NGS)

Principle: Massively parallel sequencing enables simultaneous analysis of multiple genes, whole exomes or whole genomes from FFPE tissue or liquid biopsy samples.

Sample preparation overview:

  • DNA/RNA extraction from FFPE tissue (macrodissection or microdissection for tumour enrichment)
  • Quality and quantity assessment (Qubit, Bioanalyzer/TapeStation)
  • Library preparation (fragmentation, adapter ligation, target enrichment or amplicon-based)
  • Sequencing on platform (Illumina, Ion Torrent, Oxford Nanopore)
  • Bioinformatic analysis: alignment, variant calling, annotation, clinical interpretation
In Situ Detection

In Situ Hybridization (ISH)

Principle: Labelled nucleic acid probes (DNA or RNA) hybridise to complementary sequences within intact tissue sections, preserving morphological context. Chromogenic ISH (CISH) uses enzyme-labelled probes for brightfield microscopy.

Key applications:

  • EBER (EBV-encoded RNA): Gold standard for EBV detection in tissue; nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin lymphoma
  • HPV ISH: High-risk HPV detection in cervical, oropharyngeal and anogenital carcinomas
  • Kappa/Lambda ISH: Light chain restriction in B-cell lymphomas (superior to IHC on FFPE tissue)

Tissue Processing

The systematic preparation of tissue specimens from receipt in the laboratory through to the production of stained microscope slides for diagnostic examination.

Complete Processing Workflow

1. Fixation

  • Standard fixative: 10% neutral buffered formalin (NBF) — 4% formaldehyde in phosphate buffer (pH 6.8–7.2)
  • Volume ratio: Minimum 10:1 fixative to tissue
  • Duration: 6–48 hours for routine surgical specimens; 24–72 hours optimal for most tissues
  • Breast biomarkers: 6–72 hours cold ischaemia time considerations per ASCO/CAP guidelines
  • Purpose: Preserves tissue architecture, prevents autolysis and putrefaction, cross-links proteins

2. Grossing / Macroscopic Dissection

  • Specimen description: size, weight, shape, colour, consistency
  • Identification of lesions, margins, lymph nodes
  • Inking of surgical margins (colour-coded)
  • Serial sectioning and representative block selection
  • Cassette labelling and submission for processing

3. Tissue Processing (Dehydration, Clearing, Infiltration)

  • Dehydration: Graded alcohols (70% → 80% → 95% → 100% → 100%) to remove water
  • Clearing: Xylene (or xylene substitute) replaces alcohol — tissue becomes translucent
  • Infiltration: Molten paraffin wax (56–60°C) replaces clearing agent
  • Duration: Typically 12–16 hours (overnight) in automated tissue processor
  • Rapid processing: Microwave-assisted or vacuum-assisted processors (1–4 hours)

4. Embedding

  • Orient tissue in molten paraffin wax within embedding mould
  • Correct orientation critical — determines plane of section
  • Cool on cold plate to solidify wax block
  • Attach cassette as backing for microtomy

5. Microtomy (Section Cutting)

  • Standard thickness: 3–5 μm (most routine histology)
  • Face block, cut ribbon of sections on rotary microtome
  • Float sections on warm water bath (40–45°C) to flatten
  • Pick up sections onto glass slides (charged/coated slides for IHC)
  • Dry sections (37–60°C oven or air dry)

6. Mounting and Coverslipping

  • Apply mounting medium (DPX, Pertex, or equivalent synthetic resin)
  • Place glass coverslip over section
  • Automated coverslipper for high throughput
  • Quality check: no air bubbles, complete coverage, correct labelling

Common Processing Artefacts and Solutions

  • Incomplete fixation: Soft, poorly staining tissue — ensure adequate fixation time and volume
  • Over-processing: Hard, brittle tissue — reduce processing times or use shorter schedule
  • Under-processing: Soft, difficult to section — reprocess tissue through full schedule
  • Tissue shrinkage: Caused by dehydration and heat — minimise processing temperature and duration
  • Poor orientation: Incorrect plane of section — re-embed with correct orientation
  • Thick/thin sections: Microtome calibration issue — service microtome, replace blade
  • Venetian blind artefact: Alternating thick and thin bands — caused by loose microtome clamp

Quality Control

Robust quality assurance and quality control programmes are essential to ensure reliable, reproducible and clinically accurate results in histopathology and immunohistochemistry laboratories.

IHC Controls

Positive & Negative Controls

  • External positive control: Known positive tissue run with each antibody batch to confirm the staining protocol is working correctly
  • Internal positive control: Normal tissue elements within the patient's section that are known to express the antigen (e.g. normal breast epithelium for ER)
  • Negative control: Replacement of primary antibody with isotype-matched immunoglobulin or antibody diluent to confirm specificity
  • On-slide controls: Multi-tissue microarrays (TMAs) with graded expression levels for semi-quantitative validation
  • Documentation: Record control results with every batch; investigate and document any failures
External Assessment

External Quality Assessment (EQA)

  • UK NEQAS: National External Quality Assessment Service — ICC/IHC module with regular assessment rounds for common and specialist antibodies
  • CAP Proficiency Testing: College of American Pathologists programme covering IHC, special stains, cytology and molecular pathology
  • NordiQC: Nordic immunohistochemical Quality Control programme — rigorous antibody and protocol assessment
  • Participation: Mandatory for laboratory accreditation (UKAS, CAP, ISO 15189)
  • Action on poor performance: Root cause analysis, corrective actions, re-assessment
Performance Metrics

Turnaround Time Benchmarks

  • Routine histology (small biopsies): 80% reported within 3 working days
  • Routine histology (larger specimens): 80% reported within 5 working days
  • Urgent/cancer diagnoses: 80% reported within 7 calendar days (per NHS cancer targets)
  • Frozen sections: Reported within 20 minutes of receipt
  • Immunohistochemistry: Results within 1–2 working days of request
  • Molecular tests: 5–10 working days depending on complexity
Maintenance

Equipment Maintenance Schedules

  • Daily: Temperature checks (water baths, ovens, refrigerators, freezers), microscope cleaning, reagent level checks
  • Weekly: Stainer reagent changes (H&E, special stains), microtome cleaning, processor reagent monitoring
  • Monthly: IHC stainer maintenance, tissue processor fluid changes, centrifuge checks
  • Quarterly: Thermometer calibration, pipette calibration, safety cabinet servicing
  • Annually: Full equipment service and calibration by manufacturer/accredited engineer, IHC antibody inventory review
  • Documentation: All maintenance logged in equipment logbooks; non-conformances investigated and recorded

Related Resources

Explore further educational content, clinical case studies, certification pathways and publications across the Global Pathology Publications platform.

Learning

Education & CPD

Tutorials, diagnostic guides, board exam preparation, digital pathology courses and continuing professional development resources.

Qualifications

Certifications

FRCPath, board certification, IBMS registration and specialist qualification pathways for pathologists and biomedical scientists.

Case Studies

Clinical Cases

Diagnostic challenges, rare cases, whole slide image cases and IHC case studies with expert discussion and learning points.

Research

Publications

Peer-reviewed research articles, reviews, case reports and editorials across all pathology subspecialties.

Stay Updated on Staining Protocols

Receive notifications about new protocols, technique updates, quality control guidelines and laboratory best practices.